Nevertheless, the comparison between the SWEPFT-L and Model cohorts revealed no substantial variations, indicating that SWEPFT-L administration failed to produce meaningful improvements in insulin sensitivity among the T2DM mice. This evidence concerns the gene INS and type 2 diabetes mellitus.